Table 5.
GSH-driven turn on theranostics.
Bioactive link/group | Signal reporter | Therapeutic agent | Imaging modality | Therapeutic modality | Ref. |
---|---|---|---|---|---|
S-S bond | Ce6 | Ce6 | FLI | PDT | 158 |
S-Au bond | rhodamine B | paclitaxel | FLI | CHT | 159 |
S-S bond | piperazine-rhodol | SN-38 | FLI | CHT | 160 |
S-S bond | dicyanomethylene-4H-pyran | CPT | FLI | CHT | 161 |
Sulfonyl | BODIPY | BODIPY | FLI | PDT | 162 |
Sulfonyl | ZnPc | ZnPc | FLI | PDT | 163 |
S-Au bond | PhA | PhA | FLI | PDT | 164 |
S-S bond | BODIPY | BODIPY | FLI | PDT | 165 |
S-S bond | AIEgens | AIEgen | FLI | PDT | 166 |
S-S bond | dicyanomethylene-4H-pyran | DOX | FLI | CHT | 167 |
MnO2 | Ce6 | Ce6 | FLI | PDT | 168 |
S-S bond | Ce4 | Ce4 | FLI | PDT | 169 |
S-S bond | dicyanomethylene-4H-pyran | CPT | FLI | CHT | 170 |
S-S bond | Ce6 | Ce6 | FLI | PDT | 171 |
S-S bond | Cyanine/CPT | CPT | FLI | CHT | 172 |
Sulfonyl | AIEgen | AIEgen | FLI | PDT | 173 |